Chiral discrimination in platinum anticancer drugs.
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F68081707%3A_____%2F02%3A17023089" target="_blank" >RIV/68081707:_____/02:17023089 - isvavai.cz</a>
Result on the web
—
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Chiral discrimination in platinum anticancer drugs.
Original language description
In this article the mechanism underlying biological activity of analogs of the antitumor drug cisplatin that contain chiral amine ligands is reviewed.
Czech name
—
Czech description
—
Classification
Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
BO - Biophysics
OECD FORD branch
—
Result continuities
Project
Result was created during the realization of more than one project. More information in the Projects tab.
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)<br>Z - Vyzkumny zamer (s odkazem do CEZ)
Others
Publication year
2002
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Environmental Health Perspectives
ISSN
0091-6765
e-ISSN
—
Volume of the periodical
110
Issue of the periodical within the volume
Suppl. 5
Country of publishing house
US - UNITED STATES
Number of pages
4
Pages from-to
779-782
UT code for WoS article
—
EID of the result in the Scopus database
—